z-logo
open-access-imgOpen Access
C-REACTIVE PROTEIN EFFECTS IN PATIENTS WITH BIPOLAR DEPRESSION TREATED WITH LURASIDONE: AN EXPLORATORY ANALYSIS OF A PLACEBO-CONTROLLED TRIAL
Author(s) -
Charles L. Raison,
Andrei Pikalov,
Cynthia Siu,
Joyce Tsai,
Kenneth S. Koblan,
Antony Loebel
Publication year - 2017
Publication title -
frontiers in psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.363
H-Index - 67
ISSN - 1664-0640
DOI - 10.3389/conf.fpsyt.2017.48.00029
Subject(s) - lurasidone , depression (economics) , medicine , placebo , bipolar disorder , bipolar i disorder , c reactive protein , antidepressant , population , psychiatry , psychology , antipsychotic , schizophrenia (object oriented programming) , mania , lithium (medication) , inflammation , pathology , alternative medicine , economics , macroeconomics , environmental health , hippocampus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom